In 2023, Germany's insulin import stood at 3.682 million US Dollars. The forecast shows a consistent decrease from 2024 to 2028, starting at 3.4057 million USD in 2024 and dropping to 2.316 million USD by 2028. This represents a year-on-year decline of 8.22% from 2023 to 2024. Over the five-year period, the compound annual growth rate (CAGR) is estimated at -8.29%, indicating a significant reduction in imports.
Future trends to watch for include the potential increase in local insulin production, technological advances in diabetes management, or changes in pharmaceutical trade policies, which could further impact import figures.
